Maximus, Inc. (NYSE:MMS) Shares Sold by Yousif Capital Management LLC

Yousif Capital Management LLC cut its position in shares of Maximus, Inc. (NYSE:MMS) by 3.5% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 22,043 shares of the health services provider’s stock after selling 805 shares during the quarter. Yousif Capital Management LLC’s holdings in Maximus were worth $1,646,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. DAVENPORT & Co LLC lifted its stake in Maximus by 21.1% during the fourth quarter. DAVENPORT & Co LLC now owns 40,000 shares of the health services provider’s stock valued at $2,969,000 after buying an additional 6,958 shares in the last quarter. Washington Capital Management Inc. boosted its stake in shares of Maximus by 67.3% during the 4th quarter. Washington Capital Management Inc. now owns 9,200 shares of the health services provider’s stock worth $687,000 after acquiring an additional 3,700 shares in the last quarter. Robeco Institutional Asset Management B.V. raised its position in shares of Maximus by 45.3% in the fourth quarter. Robeco Institutional Asset Management B.V. now owns 25,615 shares of the health services provider’s stock valued at $1,912,000 after purchasing an additional 7,980 shares during the period. R Squared Ltd acquired a new position in Maximus during the 4th quarter worth $54,000. Finally, KBC Group NV lifted its position in shares of Maximus by 78.1% during the 4th quarter. KBC Group NV now owns 2,905 shares of the health services provider’s stock worth $217,000 after purchasing an additional 1,274 shares during the last quarter. Institutional investors own 97.21% of the company’s stock.

Insider Buying and Selling at Maximus

In other Maximus news, Director Raymond B. Ruddy purchased 3,490 shares of the stock in a transaction dated Thursday, December 12th. The stock was bought at an average price of $71.46 per share, with a total value of $249,395.40. Following the acquisition, the director now owns 112,520 shares of the company’s stock, valued at approximately $8,040,679.20. This represents a 3.20 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Michelle F. Link sold 2,208 shares of the stock in a transaction dated Tuesday, December 3rd. The stock was sold at an average price of $73.83, for a total transaction of $163,016.64. Following the completion of the transaction, the insider now directly owns 6,567 shares of the company’s stock, valued at $484,841.61. This trade represents a 25.16 % decrease in their position. The disclosure for this sale can be found here. Insiders have purchased a total of 7,063 shares of company stock worth $502,017 over the last ninety days. Insiders own 1.60% of the company’s stock.

Maximus Trading Down 2.9 %

NYSE MMS opened at $67.68 on Wednesday. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.72 and a quick ratio of 1.49. Maximus, Inc. has a one year low of $67.20 and a one year high of $93.97. The stock’s 50-day moving average is $74.51 and its 200-day moving average is $82.95. The firm has a market cap of $3.87 billion, a P/E ratio of 14.55 and a beta of 0.72.

Maximus (NYSE:MMS) last issued its quarterly earnings results on Thursday, February 6th. The health services provider reported $1.61 EPS for the quarter, topping the consensus estimate of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. Sell-side analysts anticipate that Maximus, Inc. will post 6.05 earnings per share for the current fiscal year.

Maximus Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 28th. Stockholders of record on Saturday, February 15th will be paid a dividend of $0.30 per share. The ex-dividend date of this dividend is Friday, February 14th. This represents a $1.20 annualized dividend and a dividend yield of 1.77%. Maximus’s dividend payout ratio is currently 25.81%.

Analysts Set New Price Targets

Several equities analysts recently issued reports on the company. Raymond James upgraded Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 price target on the stock in a research note on Thursday, January 2nd. StockNews.com upgraded Maximus from a “hold” rating to a “buy” rating in a research report on Thursday, February 6th.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.